News on Solvay Pharma AG from BioPortfolio.com http://www.BioPortfolio.com Consolidated Solvay Pharma AG news from BioPortfolio.com Wed, 10 Feb 2010 16:26:03 GMT en Morphologi G3 Adds New Dimension to Solvay Pharmaceuticals R&Dhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042203&HITNO=0&MSIZE=296&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Solvay%20Pharma%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042203&THISHREF=http://c.moreover.com/click/here.pl%3fz2539355132%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042203&HITNO=0&MSIZE=296&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Solvay%20Pharma%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042203&THISHREF=http://c.moreover.com/click/here.pl%3fz2539355132%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPowder Bulk Solids: Morphologi G3 'Adds New Dimension' To Solvay Pharmaceuticals Rhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040324&HITNO=1&MSIZE=296&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Solvay%20Pharma%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040324&THISHREF=http://c.moreover.com/click/here.pl%3fz2538704214%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040324&HITNO=1&MSIZE=296&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Solvay%20Pharma%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040324&THISHREF=http://c.moreover.com/click/here.pl%3fz2538704214%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaceutical Online: Morphologi G3 adds new dimension to Solvay Pharmaceuticals R&Dhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038921&HITNO=2&MSIZE=296&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Solvay%20Pharma%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038921&THISHREF=http://c.moreover.com/click/here.pl%3fz2537837400%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038921&HITNO=2&MSIZE=296&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Solvay%20Pharma%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038921&THISHREF=http://c.moreover.com/click/here.pl%3fz2537837400%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Morphologi G3 adds new dimension to Solvay Pharmaceuticals Rhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038879&HITNO=3&MSIZE=296&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Solvay%20Pharma%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038879&THISHREF=http://c.moreover.com/click/here.pl%3fz2537819971%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038879&HITNO=3&MSIZE=296&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Solvay%20Pharma%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038879&THISHREF=http://c.moreover.com/click/here.pl%3fz2537819971%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Pharmaceutical Manufacturer Takes Full Advantage Malvern Particle Characterization System's Capabilitieshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039001&HITNO=4&MSIZE=296&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Solvay%20Pharma%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039001&THISHREF=http://c.moreover.com/click/here.pl%3fz2537866566%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039001&HITNO=4&MSIZE=296&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Solvay%20Pharma%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039001&THISHREF=http://c.moreover.com/click/here.pl%3fz2537866566%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comResearch & Development: Morphologi G3 Adds New Dimension To Solvay Pharmaceuticals Rhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040718&HITNO=5&MSIZE=296&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Solvay%20Pharma%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040718&THISHREF=http://c.moreover.com/click/here.pl%3fz2538851578%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040718&HITNO=5&MSIZE=296&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Solvay%20Pharma%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040718&THISHREF=http://c.moreover.com/click/here.pl%3fz2538851578%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioresearch Online: Solvay Pharma's Creon improves fat absorption in kids with exocrine pancreatic insufficiencyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033379&HITNO=6&MSIZE=296&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Solvay%20Pharma%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033379&THISHREF=http://c.moreover.com/click/here.pl%3fz2535169885%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033379&HITNO=6&MSIZE=296&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Solvay%20Pharma%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033379&THISHREF=http://c.moreover.com/click/here.pl%3fz2535169885%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaBiz: Morphologi G3 'adds new dimension' to Solvay Pharmaceuticals R&Dhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037253&HITNO=7&MSIZE=296&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Solvay%20Pharma%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037253&THISHREF=http://c.moreover.com/click/here.pl%3fz2536997282%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037253&HITNO=7&MSIZE=296&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Solvay%20Pharma%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037253&THISHREF=http://c.moreover.com/click/here.pl%3fz2536997282%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioPortfolio: (Reuters) EUR Abbott Laboratories is expected to win EU approval this week for its takeover of Solvay's drugshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033081&HITNO=8&MSIZE=296&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Solvay%20Pharma%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033081&THISHREF=http://c.moreover.com/click/here.pl%3fz2534991747%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033081&HITNO=8&MSIZE=296&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Solvay%20Pharma%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033081&THISHREF=http://c.moreover.com/click/here.pl%3fz2534991747%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comCrains ChicagoBusiness: CREON improves fat absorption in children with cystic fibrosishttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028883&HITNO=9&MSIZE=296&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Solvay%20Pharma%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028883&THISHREF=http://c.moreover.com/click/here.pl%3fz2532885583%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028883&HITNO=9&MSIZE=296&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Solvay%20Pharma%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028883&THISHREF=http://c.moreover.com/click/here.pl%3fz2532885583%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBio Spectrum Asia: CORRECTED-EU expected to clear Abbott, Solvay deal - sourceshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031081&HITNO=10&MSIZE=296&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Solvay%20Pharma%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031081&THISHREF=http://c.moreover.com/click/here.pl%3fz2533982145%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031081&HITNO=10&MSIZE=296&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Solvay%20Pharma%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031081&THISHREF=http://c.moreover.com/click/here.pl%3fz2533982145%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comInteractive Investor: CORRECTED-EU expected to clear Abbott, Solvay deal - sourceshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031071&HITNO=11&MSIZE=296&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Solvay%20Pharma%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031071&THISHREF=http://c.moreover.com/click/here.pl%3fz2533974847%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031071&HITNO=11&MSIZE=296&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Solvay%20Pharma%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031071&THISHREF=http://c.moreover.com/click/here.pl%3fz2533974847%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFinanzNachrichten.de: EU expected to clear Abbott, Solvay deal - sourceshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030141&HITNO=12&MSIZE=296&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Solvay%20Pharma%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030141&THISHREF=http://c.moreover.com/click/here.pl%3fz2533461787%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030141&HITNO=12&MSIZE=296&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Solvay%20Pharma%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030141&THISHREF=http://c.moreover.com/click/here.pl%3fz2533461787%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comInteractive Investor: EU expected to clear Abbott, Solvay deal - sourceshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030086&HITNO=13&MSIZE=296&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Solvay%20Pharma%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030086&THISHREF=http://c.moreover.com/click/here.pl%3fz2533432435%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030086&HITNO=13&MSIZE=296&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Solvay%20Pharma%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030086&THISHREF=http://c.moreover.com/click/here.pl%3fz2533432435%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFinanzNachrichten.de: EU expected to clear Abbott, Solvay deal - sourceshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031117&HITNO=14&MSIZE=296&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Solvay%20Pharma%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031117&THISHREF=http://c.moreover.com/click/here.pl%3fz2534002874%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031117&HITNO=14&MSIZE=296&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Solvay%20Pharma%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031117&THISHREF=http://c.moreover.com/click/here.pl%3fz2534002874%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comCNN Money: